Search Results 821-830 of 18377 for Relapse
NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to ...
The holidays can be stressful, and for those in recovery it's a time to be vigilant against relapse. Fountain Centers, a Mayo Clinic Health System ...
Mayo Clinic researchers link CAR-T cell aging to cancer relapse · (VIDEO) When valley fever spreads: Meet Chris and his complex case. Related Articles. Mayo ...
The purpose of this study is to compare IgG4-related disease remission and relapse rates between patients who had induction rituximab treatment with or ...
Mayo Clinic researchers link CAR-T cell aging to cancer relapse featured image. Featured News. Mayo Clinic researchers link CAR-T cell aging to cancer relapse.
The Food and Drug Administration has only approved three drugs for this disorder, and the relapse rate is high. "When I met him in 2016,' says Dr. Choi, "he ...
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL. Rochester, Minn. This is a Phase 2 global, multi-center, open-label study ...
... relapsed acute leukemia (AML or ALL) for future biological studies. By accruing samples both at initial diagnosis and at relapse, we will be able to ...
Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS. Rochester, Minn., Mankato, Minn., La Crosse, Wis., Eau ...
... relapsed lymphoma. For nodular lymphocyte-predominant ... You may have repeat blood and imaging tests and, if needed, biopsies, to check for a relapse.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.